Position in FTRE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,533,218
+$1,503,734 QoQ
Shares Held
88,116
+2715.2% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#92
of 327 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $59,650,000 across 287 Biotechnology names. FTRE ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
118,402 | $13,422,050 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,563 | $5,962,913 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,844 | $4,167,459 | |
| 4 | EXEL |
Exelixis, Inc.
|
70,160 | $3,817,405 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
66,469 | $2,592,955 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,662 | $2,315,755 | |
| 7 | MESO |
Mesoblast Ltd
|
168,022 | $2,273,337 | |
| 8 | FTRE |
Fortrea Holdings Inc.
This page
|
88,116 | $1,533,218 |
All Filings in FTRE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,533,218 | 88,116 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $29,484 | 3,130 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $13,989 | 811 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $814,070 | 96,683 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,151 | 638 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,096 | 675 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,353 | 716 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $7,620 | 381 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $10,269 | 440 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $16,858 | 420 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $14,762 | 423 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $12,064 | 422 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||